COMMUNIQUÉS West-GlobeNewswire

U.S. Oral Surgery Management Names Doug Drew CEO
02/07/2025
Richard Hall to Serve as Chairman of the Board IRVING, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) developed and implemented a succession plan earlier this year to ensure a smooth [...]
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
02/07/2025
US phase 1 trial of ‘2510 is expected to be initiated before the end of 2025 Anticipate ImmuneOnco sharing initial safety and efficacy results from phase 2 trial of ‘2510 + chemo in 1L NSCLC in the second half of 2025 [...]
The Ensign Group Purchases Skilled Nursing Facility in Texas
02/07/2025
SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Continues Growth in Idaho
02/07/2025
SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
02/07/2025
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host 1x1 meetings at [...]
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
02/07/2025
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) [...]
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
02/07/2025
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private [...]
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
02/07/2025
Combination treatment of mTNX-1700 (mTFF2-MSA fusion protein) with anti-PD1 antibody was associated with increased survival and decreased metastases in animal models of gastric cancer relative to anti-PD1 treatment [...]
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
02/07/2025
Pelthos plans to launch ZELSUVMI™ for the treatment of Molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, Ligand has invested $18 million in the combined company and is entitled to [...]
Dr. Oetker monte sur scène avec Suprema, une nouvelle pizza surgelée sophistiquée célébrée par un spectacle d'opéra personnalisé
02/07/2025
Opéra personnalisé. Pizza de qualité supérieure. Des débuts spectaculaires au centre-ville de Toronto TORONTO, 02 juill. 2025 (GLOBE NEWSWIRE) -- Pour marquer le lancement de son produit le plus audacieux en plus de [...]
Dr. Oetker Takes the Stage with Suprema – A Sophisticated New Frozen Pizza Celebrated Through a Custom Opera Performance
02/07/2025
Custom opera. Premium pizza. A dramatic debut in downtown Toronto TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- To mark its boldest product launch in over two decades, Dr. Oetker Canada is introducing Suprema not just as a [...]
Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
02/07/2025
SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA ® (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. [...]
OSE Immunotherapeutics met à jour l’information sur les procédures en cours
02/07/2025
OSE Immunotherapeutics met à jour l’information sur les procédures en cours NANTES, France, 2 juillet 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) annonce qu’à la suite de l’audience du [...]
OSE Immunotherapeutics met à jour l’information sur les procédures en cours
02/07/2025
OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that following the hearing on June 24th, 2025, [...]
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch
02/07/2025
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both Type 2 diabetic [...]
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
02/07/2025
- 500 subjects enrolled across the United States, the United Kingdom, France, Czech Republic, Switzerland, China, Taiwan, and Australia SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a [...]
ArriVent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
02/07/2025
NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical [...]
BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate
02/07/2025
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, July 02, 2025 (GLOBE NEWSWIRE) -- The Global Research Collaboration is a research and exclusive license option agreement with Shionogi to jointly develop [...]
Granting of Stock Options and Vesting of Restricted Share Units
02/07/2025
In accordance with the Remuneration Policy of Alvotech (the “Company”), which was approved at the Company’s Annual General Meeting (“AGM”) on June 6, 2023, at the 2025 AGM held on June 25, 2025, four independent board [...]

Pages